Asthma treatment with combination inhaler
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new combination inhaler for people with asthma. It may help control symptoms and improve breathing. Participants will either get the study inhaler or a standard treatment, and their asthma will be monitored closely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with asthma for at least 3 months.
- Your asthma is not well controlled with your current inhaler, or it is well controlled if you use a combination inhaler.
- You are willing to switch to the study's rescue inhaler for symptom relief.
- You have not smoked for at least 6 months (and your lifetime smoking history is less than 10 pack-years).
- You do not have other significant lung diseases (like COPD or bronchiectasis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether starting treatment with a combination anti-inflammatory and reliever inhaler can help people with new, mild asthma control their symptoms better. It compares different treatment strategies to find the best approach for early asthma care.
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
This study compares a three-in-one inhaler (ICS/LABA/LAMA) to a two-in-one inhaler (ICS/LABA) for adults whose asthma is not well-controlled despite using a standard two-in-one inhaler. The goal is to see if the triple inhaler improves asthma control better.
This trial uses special imaging to look at how air moves through your lungs. It may help doctors understand asthma better and could lead to better treatments.
This trial tests if a new combination inhaler (formoterol/fluticasone) works as well as an existing one (Alenia) for people with moderate asthma. You may be able to join if your asthma is stable and well controlled with your current treatment.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
Hear when a new Asthma (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.